Your browser doesn't support javascript.
loading
Avelumab in Combination With Cetuximab and Chemotherapy as First-Line Treatment for Patients With Advanced Squamous NSCLC.
Andric, Zoran; Gálffy, Gabriella; Cobo Dols, Manuel; Szima, Barna; Stojanovic, Goran; Petrovic, Marina; Felip, Enriqueta; Vicente Baz, David; Ponce Aix, Santiago; Juan-Vidal, Oscar; Szalai, Zsuzsanna; Losonczy, Gyorgy; Calles Blanco, Antonio; Bernabe, Reyes; García Ledo, Gema; Aguilar Hernández, Andrés; Duecker, Klaus; Zhou, Dongli; Schroeder, Andreas; Guezel, Guelseren; Ciardiello, Fortunato.
Afiliação
  • Andric Z; Department of Medical Oncology, Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia.
  • Gálffy G; Pulmonology Hospital Törökbálint, Törökbálint, Hungary.
  • Cobo Dols M; Department of Medical Oncology, Hospital Regional Universitario de Málaga, Institute of Biomedical Research of Málaga (IBIMA), Málaga, Spain.
  • Szima B; Department of Pulmonology, Markusovszky Hospital, Szombathely, Hungary.
  • Stojanovic G; Institute of Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia.
  • Petrovic M; Clinic for Pulmonology, Clinical Center Kragujevac, Kragujevac, Serbia.
  • Felip E; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Vicente Baz D; Department of Medical Oncology, Hospital Universitario Virgen Macarena, Seville, Spain.
  • Ponce Aix S; Medical Oncology Department, H120-CNIO Lung Cancer Unit, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Juan-Vidal O; Department of Medical Oncology, Hospital Universitari I Politècnic La Fe, Valencia, Spain.
  • Szalai Z; Department of Pulmonology, Aladar Petz University Teaching Hospital, Gyor, Hungary.
  • Losonczy G; Faculty of Medicine, Semmelweis University, Budapest, Hungary.
  • Calles Blanco A; Medical Oncology Department, Hospital General Universitario Gregorio Marañon, Madrid, Spain.
  • Bernabe R; Department of Medical Oncology, Hospital Universitario Virgen del Rocio, Seville, Spain.
  • García Ledo G; Centro Integral Oncológico Clara Campal HM CIOCC, Hospital Universitario HM Sanchinarro, Madrid, Spain.
  • Aguilar Hernández A; Instituto Oncológico Dr Rosell, Hospital Universitari Quiron Dexeus, Barcelona, Spain.
  • Duecker K; The Healthcare Business of Merck KGaA, Darmstadt, Germany.
  • Zhou D; Merck Serono (Beijing) Pharmaceutical R&D Co., Ltd., Beijing, China.
  • Schroeder A; The Healthcare Business of Merck KGaA, Darmstadt, Germany.
  • Guezel G; The Healthcare Business of Merck KGaA, Darmstadt, Germany.
  • Ciardiello F; Division of Medical Oncology, Department of Precision Medicine, The University of Campania Luigi Vanvitelli, Naples, Italy.
JTO Clin Res Rep ; 4(2): 100461, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36718142

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: JTO Clin Res Rep Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: JTO Clin Res Rep Ano de publicação: 2023 Tipo de documento: Article